Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

被引：0
|
作者：
Valsecchi, Matias Emanuel
Littman, Susan Joy
Holdbrook, Thomas
Leiby, Benjamin
Mitchell, Edith P.
Yeo, Charles
Brody, Jonathan Robert
Witkiewicz, Agnieszka
机构：
[1] Thomas Jefferson Univ Hosp, Dept Med Oncol, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA USA
[3] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
[4] Thomas Jefferson Univ, Jefferson Med Coll, Div Biostat, Dept Pharmacol & Expt Therapeut, Philadelphia, PA USA
[5] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA USA
[6] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.246
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
246
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PROGNOSTIC VALUE OF CD133 EXPRESSION AND IT'S COMBINATION WITH EXPRESSIONS OF ERCC1, RRM1 AND BRCA1 IN LUNG CANCER
    Su, C.
    Xu, G.
    Zhou, C.
    [J]. RESPIROLOGY, 2011, 16 : 185 - 185
  • [32] ERCC1、RRM1在非小细胞肺癌临床中的应用进展
    冷雪峰
    王革平
    [J]. 中华临床医师杂志(电子版), 2013, 7 (20) : 9269 - 9271
  • [33] Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?
    Rebecca S Heist
    Geoffrey Liu
    Wei Zhou
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 564 - 565
  • [34] ERCC1、RRM1基因与非小细胞肺癌治疗预后的关系
    刘斌
    刘德森
    [J]. 中国癌症防治杂志, 2012, 4 (01) : 91 - 93
  • [35] The Prognostic Significance of ERCC1, RRM1, MMP7 and VEGF Expression in Locally Advanced Pancreatic Cancer Patients Treated with Gemcitabine-based Radiochemotherapy
    Demirci, S.
    Ozkok, S.
    Nart, D.
    Yalman, D.
    Argon, A.
    Coker, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S334 - S334
  • [36] Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?
    Heist, Rebecca S.
    Liu, Geoffrey
    Zhou, Wei
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (10): : 564 - 565
  • [37] In Situ Protein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy
    Metro, G.
    Zheng, Z.
    Fabi, A.
    Schell, M.
    Antoniani, B.
    Mottolese, M.
    Monteiro, A. N.
    Vici, P.
    Rivera, S. Lara
    Boulware, D.
    Cognetti, F.
    Bepler, G.
    [J]. CANCER INVESTIGATION, 2010, 28 (02) : 172 - 180
  • [38] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Chunxia Su
    Songwen Zhou
    Ling Zhang
    Shengxiang Ren
    Jianfang Xu
    Jie Zhang
    Meijun Lv
    Jie Zhang
    Caicun Zhou
    [J]. Medical Oncology, 2011, 28 : 1411 - 1417
  • [39] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Su, Chunxia
    Zhou, Songwen
    Zhang, Ling
    Ren, Shengxiang
    Xu, Jianfang
    Zhang, Jie
    Lv, Meijun
    Zhang, Jie
    Zhou, Caicun
    [J]. MEDICAL ONCOLOGY, 2011, 28 (04) : 1411 - 1417
  • [40] In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-including chemotherapy
    Metro, G.
    Zheng, Z.
    Fabi, A.
    Mottolese, M.
    Monteiro, A. N.
    Vici, P.
    Boulware, D.
    Rivera, S. Lara
    Cognetti, F.
    Bepler, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345